|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 来那卡韦>> 市场分析报告 |
来那卡韦市场分析报告 |
|
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030 ... segments namely, Biktarvy, Cabenuva, Sunlenca (lenacapavir), Islatravir, Genvoya, Odefsey, bNAbs, ... several groundbreaking products like Sunlenca (lenacapavir), VH184, Capsid, bNAbs, and ... 's recent FDA application for lenacapavir, a long-acting HIV-1 capsid ... Capsid protein inhibitors - Pipeline Insight, 2022 ... inhibitors Emerging Drugs Lenacapavir: Gilead Sciences Lenacapavir is a potential first-in-class ... and prevention of HIV-1 infection. Lenacapavir's multi-stage mechanism of action ... one stage of viral replication, lenacapavir is designed to inhibit HIV-1 at ... Global HIV Prevention Drug Market Growth 2024-2030 ... regions and countries. Segmentation by Type: Lenacapavir Cabotegravir Segmentation by Application: Hospital Clinic ... 2025-2030 Global HIV Prevention Drug Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region ... : Gilead Sciences ViiV Healthcare By Type Lenacapavir Cabotegravir By Application Hospital Clinic Others ... HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033 ... 3 PURPOSE 2 trial results on twice-yearly lenacapavir for HIV prevention at HIV Glasgow ... . The research demonstrated lenacapavir lowered HIV infections by 96%, beating Truvada ... Human Immunodeficiency Virus Type-1 Market - A Global and Regional Analysis: Focus on Drug Class and Regional Analysis - Analysis and Forecast, 2025-2035 ... manufacture and commercialization of the drug Lenacapavir in India and 120 other countries ... 2022, the U.S. FDA approved Sunlenca (lenacapavir), a new type of antiretroviral medication for ... Oncology Drugs Market Forecasts to 2032 – Global Analysis By Drug Class (Cytotoxic Drugs, Targeted Therapy Drugs, Hormonal Therapy Drugs, Immunotherapy Drugs, and Other Drug Classes), Therapy Type, Cancer Type, Dosage Form, Distribution Channel, and By Geography ... Plan for AIDS Relief to deliver lenacapavir Gilead's twice-yearly injectable HIV ... Global Fund, to further advance access to lenacapavir for PrEP for up to two million ... Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major human immunodeficiency virus type 1 markets reached a value of US$ 24.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 39.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.56% during 2024-2034. The human ... Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major sexually transmitted disease markets reached a value of US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.01% during 2024-2034. The sexually ... North America HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Country, 2025-2033 ... Drug Application to the FDA for lenacapavir as a twice-yearly injectable HIV-1 prevention ... Global HIV Prevention Drug Market Research Report 2025(Status and Outlook) ... ViiV Healthcare Market Segmentation (by Type) Lenacapavir Cabotegravir Market Segmentation (by Application) Hospital ... Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review ... long-acting, Investigational treatment combinations of Lenacapavir and Islatravir in HIV Mar 04,2021 ... Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the ... |